Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
19 10 2023
Historique:
accepted: 16 06 2023
received: 27 02 2023
medline: 1 11 2023
pubmed: 19 10 2023
entrez: 19 10 2023
Statut: ppublish

Résumé

The correlation existing between gut microbiota diversity and survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has so far been studied in adults. Pediatric studies question whether this association applies to children as well. Stool samples from a multicenter cohort of 90 pediatric allo-HSCT recipients were analyzed using 16S ribosomal RNA amplicon sequencing to profile the gut microbiota and estimate diversity with the Shannon index. A global-to-local networking approach was used to characterize the ecological structure of the gut microbiota. Patients were stratified into higher- and lower-diversity groups at 2 time points: before transplantation and at neutrophil engraftment. The higher-diversity group before transplantation exhibited a higher probability of overall survival (88.9% ± 5.7% standard error [SE] vs 62.7% ± 8.2% SE; P = .011) and lower incidence of grade 2 to 4 and grade 3 to 4 acute graft-versus-host disease (aGVHD). No significant difference in relapse-free survival was observed between the 2 groups (80.0% ± 6.0% SE vs 55.4% ± 10.8% SE; P = .091). The higher-diversity group was characterized by higher relative abundances of potentially health-related microbial families, such as Ruminococcaceae and Oscillospiraceae. In contrast, the lower-diversity group showed an overabundance of Enterococcaceae and Enterobacteriaceae. Network analysis detected short-chain fatty acid producers, such as Blautia, Faecalibacterium, Roseburia, and Bacteroides, as keystones in the higher-diversity group. Enterococcus, Escherichia-Shigella, and Enterobacter were instead the keystones detected in the lower-diversity group. These results indicate that gut microbiota diversity and composition before transplantation correlate with survival and with the likelihood of developing aGVHD.

Identifiants

pubmed: 37856089
pii: 497377
doi: 10.1182/blood.2023020026
pmc: PMC10651870
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1387-1398

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Int J Mol Sci. 2021 Jan 26;22(3):
pubmed: 33530464
Front Cell Infect Microbiol. 2021 Nov 22;11:757718
pubmed: 34881193
N Engl J Med. 2020 Feb 27;382(9):822-834
pubmed: 32101664
Blood. 2022 Apr 14;139(15):2392-2405
pubmed: 34653248
Bone Marrow Transplant. 2017 Jan;52(1):7-14
pubmed: 27348539
Int J Syst Bacteriol. 1994 Jan;44(1):137-42
pubmed: 8123557
Int Immunol. 2019 Jul 30;31(8):499-514
pubmed: 30809639
Commun Biol. 2023 Jan 13;6(1):36
pubmed: 36639555
Blood. 2018 Jun 28;131(26):2978-2986
pubmed: 29674425
Sci Rep. 2015 Nov 06;5:16148
pubmed: 26541096
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Bone Marrow Transplant. 2019 Jul;54(7):1115-1117
pubmed: 30498199
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Blood. 2011 Dec 15;118(25):6683-90
pubmed: 22010101
Gut Microbes. 2021 Jan-Dec;13(1):1987783
pubmed: 34693878
Microbiome. 2019 Sep 13;7(1):131
pubmed: 31519210
Front Microbiol. 2014 May 20;5:219
pubmed: 24904535
Cancers (Basel). 2022 Apr 12;14(8):
pubmed: 35454840
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2247-52
pubmed: 24390544
Biol Blood Marrow Transplant. 2009 Mar;15(3):360-6
pubmed: 19203727
Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
Sci Rep. 2020 Jan 23;10(1):1040
pubmed: 31974429
Bone Marrow Transplant. 2008 Jan;41(2):215-21
pubmed: 17934526
Ann Hematol. 2017 Sep;96(9):1517-1523
pubmed: 28733895
Front Nutr. 2022 Oct 20;9:993668
pubmed: 36337625
Blood. 2020 Jul 2;136(1):130-136
pubmed: 32430495
Curr Microbiol. 2022 Mar 14;79(5):128
pubmed: 35287182
Biol Blood Marrow Transplant. 2017 May;23(5):820-829
pubmed: 28192251
Sci Rep. 2019 Apr 4;9(1):5649
pubmed: 30948795
Blood. 2014 Aug 14;124(7):1174-82
pubmed: 24939656
Trends Microbiol. 2022 Feb;30(2):104-108
pubmed: 34893402
Pediatr Blood Cancer. 2013 Sep;60(9):1520-7
pubmed: 23733511
Blood Adv. 2021 Nov 23;5(22):4619-4629
pubmed: 34610115
Ther Adv Hematol. 2020 Jan 20;11:2040620719896961
pubmed: 32010434
Bone Marrow Transplant. 2015 Jul;50(7):992-8
pubmed: 25893458
Nat Microbiol. 2017 Aug 24;2:17121
pubmed: 28836573
Hematol Transfus Cell Ther. 2020 Jan - Mar;42(1):5-11
pubmed: 31519531
Microbiome. 2022 Jun 10;10(1):89
pubmed: 35689247
J Clin Med. 2021 Aug 25;10(17):
pubmed: 34501237
Biol Blood Marrow Transplant. 2015 Aug;21(8):1373-83
pubmed: 25977230
Bone Marrow Transplant. 2020 Jul;55(7):1506-1508
pubmed: 31659235
Biol Blood Marrow Transplant. 2018 Dec;24(12):2418-2424
pubmed: 30055351
BMC Bioinformatics. 2012 Feb 14;13:31
pubmed: 22333067
J Clin Oncol. 2004 Dec 15;22(24):4872-80
pubmed: 15520055
Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Sep;80(3 Pt 2):036115
pubmed: 19905188
BMC Cancer. 2021 Feb 18;21(1):177
pubmed: 33602150
Nutrients. 2019 Dec 19;12(1):
pubmed: 31861722
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Pediatr Blood Cancer. 2020 Dec;67(12):e28711
pubmed: 32939928
BMC Med Genomics. 2019 Mar 7;12(1):49
pubmed: 30845942
ISME J. 2021 Jun;15(6):1722-1734
pubmed: 33452480
Ann Hematol. 2022 Nov;101(11):2497-2506
pubmed: 36038660
Science. 2019 Jul 12;365(6449):
pubmed: 31296739
Nutrients. 2019 Dec 04;11(12):
pubmed: 31817158
Clin Infect Dis. 2022 Mar 1;74(4):614-621
pubmed: 34043764
Biol Blood Marrow Transplant. 2016 May;22(5):902-9
pubmed: 26860636
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Transplant Cell Ther. 2021 Feb;27(2):180.e1-180.e8
pubmed: 33830034
Transplantation. 1974 Oct;18(4):295-304
pubmed: 4153799
ISME J. 2017 Nov;11(11):2426-2438
pubmed: 28731477
Blood. 2022 Dec 1;140(22):2385-2397
pubmed: 35969834
Bone Marrow Transplant. 2017 Dec;52(12):1643-1650
pubmed: 28967895
Trends Microbiol. 2019 Dec;27(12):997-1010
pubmed: 31474424
Gut Microbes. 2021 Jan-Dec;13(1):1-21
pubmed: 33525961
Microbiome. 2018 May 17;6(1):90
pubmed: 29773078
ISME J. 2014 Jun;8(6):1323-35
pubmed: 24553467
Microbiome. 2021 Jun 28;9(1):148
pubmed: 34183060
Science. 2019 Nov 29;366(6469):1143-1149
pubmed: 31780560
Blood Rev. 2019 Mar;34:34-44
pubmed: 30467067
Microorganisms. 2021 Sep 05;9(9):
pubmed: 34576776
Microbiome. 2021 May 20;9(1):115
pubmed: 34016163
Cell Host Microbe. 2021 May 12;29(5):765-776.e3
pubmed: 33794185
Nat Immunol. 2016 May;17(5):505-513
pubmed: 26998764
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Sci Rep. 2021 Jul 12;11(1):14307
pubmed: 34253759
Genome Med. 2016 Apr 28;8(1):49
pubmed: 27121964

Auteurs

Riccardo Masetti (R)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Davide Leardini (D)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Edoardo Muratore (E)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Marco Fabbrini (M)

Department of Medical and Surgical Sciences, Microbiomics Unit, University of Bologna, Bologna, Italy.
Department of Pharmacy and Biotechnology, Unit of Microbiome Science and Biotechnology, University of Bologna, Bologna, Italy.

Federica D'Amico (F)

Department of Medical and Surgical Sciences, Microbiomics Unit, University of Bologna, Bologna, Italy.

Daniele Zama (D)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Francesco Baccelli (F)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Francesca Gottardi (F)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Tamara Belotti (T)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Marek Ussowicz (M)

Department and Clinic of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.

Jowita Fraczkiewicz (J)

Department and Clinic of Pediatric Oncology, Hematology and Bone Marrow Transplantation, Wrocław Medical University, Wrocław, Poland.

Simone Cesaro (S)

Department of Mother and Child, Pediatric Hematology Oncology Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Marco Zecca (M)

Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Pietro Merli (P)

Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.

Marco Candela (M)

Department of Pharmacy and Biotechnology, Unit of Microbiome Science and Biotechnology, University of Bologna, Bologna, Italy.

Andrea Pession (A)

Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Franco Locatelli (F)

Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
Catholic University of the Sacred Heart, Rome, Italy.

Arcangelo Prete (A)

Pediatric Oncology and Hematology "Lalla Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Patrizia Brigidi (P)

Department of Medical and Surgical Sciences, Microbiomics Unit, University of Bologna, Bologna, Italy.

Silvia Turroni (S)

Department of Pharmacy and Biotechnology, Unit of Microbiome Science and Biotechnology, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH